Abstract Background Exercise induces changes in several organs and tissues, and this process might be due to oxidative damage caused by free radicals and inflammatory mediators
New Science Suggests Semaglutide Improves CV Outcomes Beyond Weight Loss Semaglutide, the popular anti-obesity medication originally developed to treat diabetes, continues to show cardiovascular benefits beyond weight loss, including reducing risk of death, reducing serious COVID-19-related events and improving heart failure (HF) symptoms, according to six new substudies published in JACC
Many people who start taking it for metabolic support notice improvements in areas they didn't expect
[DOI] [PubMed] [Google Scholar] 33.Miyashita-Ishiwata M., El Sabeh M., Reschke L.D., Afrin S., Borahay M.A
The temporal relationship strongly suggests tirzepatide as a likely trigger
Archived (PDF) from the original on 9 October 2022